Compounds > lipoxin a4

lipoxin a4 and eicosapentaenoic acid

lipoxin a4 has been researched along with eicosapentaenoic acid in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (15.00)18.2507
2000's3 (15.00)29.6817
2010's10 (50.00)24.3611
2020's4 (20.00)2.80

Authors

AuthorsStudies
Blotman, F; Chavis, C; Leroux, JL; Thomas, E1
Barrow, SE; Lloyd-Evans, P; Rowley, AF; Serhan, CN1
Gmiński, J; Stajszczyk, M1
Schwab, JM; Serhan, CN1
Baumgart, DC; Kang, JX; Weylandt, KH; Wiedenmann, B1
Cernadas, M; Haworth, O; Levy, BD; Serhan, CN; Yang, R1
Antony, R; Arita, M; Bazan, NG; Hong, S; Marcheselli, VL; Mukherjee, PK; Petasis, NA; Serhan, CN; Sheets, K; Winkler, JW1
Agerberth, B; Godson, C; Guiry, PJ; Haeggström, JZ; Wan, M1
Braegger, C; Hersberger, M; Klinke, G; Rogler, D; Troxler, H; Weiss, GA1
Bao, JJ; Ding, H; Hu, C; Liu, XC; Mei, Q; Xu, JM; Zhao, XW1
Abbasinazari, M; Abdi, S; Ahmadpour, F; Dabir, S; Fatehi, S; Hatami, B; Mohammad Alizadeh, AH; Nematollahi, A; Pourhoseingholi, MA1
Muralikumar, S; N Das, U; Narayanasamy, A; Vetrivel, U1
Das, UN; Gundala, NKV; Naidu, VGM1
Aytan, N; Benincasa, C; Carreras, I; Crabtree, L; Dedeoglu, A; Jenkins, BG; Kantarci, A; Palaska, I; Stephens, D1
Colas, RA; Dalli, J; De Maeyer, RP; Flint, JD; George, MJ; Gilroy, DW; Motwani, MP; Richard-Loendt, A; Serhan, CN1
da Silva, RF; da-Palma-Cruz, M; de Oliveira, APL; Grabulosa, CC; Lino-Dos-Santos-Franco, A; Monteiro, D; Rehim, HMMA1
Dec, K; Drozd, A; Jakubczyk, K; Maciejewska, D; Pilutin, A; Skonieczna-Żydecka, K; Skórka-Majewicz, M; Stachowska, E1
Akgül, Ö; Özdemir, AT; Özgül Özdemir, RB; Soysal Gündüz, Ö1
Özdemir, AT; Yücel, H1
Liu, X; Pan, L; Pang, L; Wang, C; Zhang, Q1

Reviews

3 review(s) available for lipoxin a4 and eicosapentaenoic acid

ArticleYear
[Lipoxins--new arachidonic acid-derived molecules].
    Postepy higieny i medycyny doswiadczalnej, 1993, Volume: 47, Issue:2

    Topics: Animals; Arachidonic Acids; Eicosapentaenoic Acid; Humans; Hydroxyeicosatetraenoic Acids; Lipoxins

1993
Lipoxins and new lipid mediators in the resolution of inflammation.
    Current opinion in pharmacology, 2006, Volume: 6, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Aspirin; Disease Models, Animal; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Inflammation; Lipid Metabolism; Lipoxins; Signal Transduction

2006
Lipoxins and resolvins in inflammatory bowel disease.
    Inflammatory bowel diseases, 2007, Volume: 13, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Inflammatory Bowel Diseases; Lipoxins; Treatment Outcome

2007

Trials

2 trial(s) available for lipoxin a4 and eicosapentaenoic acid

ArticleYear
Effect of diclofenac on the levels of lipoxin A4 and Resolvin D1 and E1 in the post-ERCP pancreatitis.
    Digestive diseases and sciences, 2014, Volume: 59, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopic Retrograde; Diclofenac; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Lipoxins; Pancreatitis

2014
Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:3

    Topics: Administration, Rectal; Adult; Aged; Amylases; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cholangiopancreatography, Endoscopic Retrograde; Diclofenac; Double-Blind Method; Eicosapentaenoic Acid; Female; Humans; Incidence; Indomethacin; Iran; Lipase; Lipoxins; Male; Middle Aged; Naproxen; Pancreatitis; Risk Factors; Time Factors; Treatment Outcome

2017

Other Studies

15 other study(ies) available for lipoxin a4 and eicosapentaenoic acid

ArticleYear
Conversion of endogenous arachidonic acid to 5,15-diHETE and lipoxins by polymorphonuclear cells from patients with rheumatoid arthritis.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1995, Volume: 44, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Arachidonic Acid; Arthritis, Rheumatoid; Calcimycin; Chromatography, High Pressure Liquid; Eicosapentaenoic Acid; Female; Humans; Hydroxyeicosatetraenoic Acids; Lipoxins; Male; Middle Aged; Neutrophils; Spectrophotometry, Ultraviolet

1995
Lipoxin biosynthesis by trout macrophages involves the formation of epoxide intermediates.
    Biochemistry, 1994, Feb-01, Volume: 33, Issue:4

    Topics: Animals; Arachidonic Acids; Calcimycin; Cells, Cultured; Culture Media, Conditioned; Eicosapentaenoic Acid; Epoxy Compounds; Hydroxyeicosatetraenoic Acids; Kinetics; Leukotrienes; Lipoxins; Lipoxygenase; Macrophages; Oncorhynchus mykiss; Zymosan

1994
Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation.
    Nature immunology, 2008, Volume: 9, Issue:8

    Topics: Animals; Asthma; Disease Models, Animal; Eicosapentaenoic Acid; Inflammation; Inflammation Mediators; Interferon-gamma; Interleukin-23; Lipoxins; Lung; Mice

2008
Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils.
    Prostaglandins, leukotrienes, and essential fatty acids, 2010, Volume: 82, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Binding, Competitive; Cell Line; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Eicosapentaenoic Acid; Epoxy Compounds; Humans; Hydrogen Peroxide; Isomerism; Kinetics; Lipoxins; Neuroprotective Agents; Neutrophils; Oxidative Stress; Retinal Pigment Epithelium; Tumor Necrosis Factor-alpha

2010
Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:5

    Topics: Antimicrobial Cationic Peptides; Blotting, Western; Calcium; Cathelicidins; Cells, Cultured; Eicosapentaenoic Acid; Electrophoresis, Polyacrylamide Gel; Group IV Phospholipases A2; Humans; Immunoenzyme Techniques; Leukotriene B4; Lipoxins; Neutrophils; Receptors, Formyl Peptide; Receptors, Leukotriene B4; Receptors, Lipoxin

2011
High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation.
    Lipids in health and disease, 2013, Jun-15, Volume: 12

    Topics: Docosahexaenoic Acids; Eicosanoids; Eicosapentaenoic Acid; Female; Humans; Infant; Infant, Newborn; Inflammation; Lactation; Lipid Metabolism; Lipoxins; Milk, Human; United States

2013
Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties.
    Lipids in health and disease, 2017, Jan-21, Volume: 16, Issue:1

    Topics: alpha-Linolenic Acid; Anti-Inflammatory Agents; Arachidonic Acid; Binding Sites; Docosahexaenoic Acids; Eicosapentaenoic Acid; gamma-Linolenic Acid; Humans; Kinetics; Linoleic Acid; Linoleic Acids; Lipoxins; Molecular Docking Simulation; Molecular Dynamics Simulation; PPAR gamma; Protein Binding; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Rosiglitazone; Thermodynamics; Thiazolidinediones

2017
Arachidonic acid and lipoxinA4 attenuate streptozotocin-induced cytotoxicity to RIN5 F cells in vitro and type 1 and type 2 diabetes mellitus in vivo.
    Nutrition (Burbank, Los Angeles County, Calif.), 2017, Volume: 35

    Topics: Animals; Apoptosis; Arachidonic Acid; Blood Glucose; Cell Line; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Docosahexaenoic Acids; Eicosapentaenoic Acid; gamma-Linolenic Acid; Glucose Transporter Type 2; Homeodomain Proteins; Lipoxins; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide Synthase Type II; Pancreas; Rats; Rats, Wistar; Trans-Activators; Tumor Necrosis Factor-alpha

2017
Combined administration of resolvin E1 and lipoxin A4 resolves inflammation in a murine model of Alzheimer's disease.
    Experimental neurology, 2018, Volume: 300

    Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Hippocampus; Inflammation; Lipoxins; Mice; Mice, Transgenic

2018
Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
    JCI insight, 2018, 03-22, Volume: 3, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; Adolescent; Adult; Anti-Inflammatory Agents; Blister; Chemokines; Cytokines; Docosahexaenoic Acids; Eicosanoids; Eicosapentaenoic Acid; Escherichia coli; Humans; Inflammation; Leukocytes; Lipoxins; Male; Middle Aged; Neutrophils; Receptors, Chemokine; Receptors, Formyl Peptide; Receptors, G-Protein-Coupled; Receptors, Lipoxin; Skin; Volunteers; Young Adult

2018
Photobiomodulation modulates the resolution of inflammation during acute lung injury induced by sepsis.
    Lasers in medical science, 2019, Volume: 34, Issue:1

    Topics: Acute Lung Injury; Animals; Bone Marrow; Bronchoalveolar Lavage; Cell Movement; Cholinergic Agents; Cytokines; Eicosapentaenoic Acid; Inflammation; Lipopolysaccharides; Lipoxins; Low-Level Light Therapy; Lung; Male; Mice, Inbred BALB C; Muscle Contraction; Muscle, Smooth; Sepsis

2019
Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?
    Molecules (Basel, Switzerland), 2020, Apr-27, Volume: 25, Issue:9

    Topics: Animals; Biomarkers; Chromatography, Liquid; Dinoprostone; Disease Models, Animal; Disease Progression; Docosahexaenoic Acids; Eicosanoids; Eicosapentaenoic Acid; Hydroxyeicosatetraenoic Acids; Linoleic Acids; Lipoxins; Liver; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley

2020
Low levels of pro-resolving lipid mediators lipoxin-A4, resolvin-D1 and resolvin-E1 in patients with rheumatoid arthritis.
    Immunology letters, 2020, Volume: 227

    Topics: Adult; Aged; Arthritis, Rheumatoid; Cytokines; Disease Progression; Docosahexaenoic Acids; Eicosapentaenoic Acid; Female; Humans; Inflammation; Inflammation Mediators; Lipid Metabolism; Lipoxins; Male; Middle Aged

2020
Low LXA4, RvD1 and RvE1 levels may be an indicator of the development of hypertension.
    Prostaglandins, leukotrienes, and essential fatty acids, 2021, Volume: 174

    Topics: Adult; Arachidonate 15-Lipoxygenase; Blood Pressure; Cholesterol; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Lipoproteins, LDL; Lipoxins; Male; Middle Aged; Oxidation-Reduction; Risk Factors

2021
Combination of resolvin E1 and lipoxin A4 promotes the resolution of pulpitis by inhibiting NF-κB activation through upregulating sirtuin 7 in dental pulp fibroblasts.
    Cell proliferation, 2022, Volume: 55, Issue:5

    Topics: Dental Pulp; Eicosapentaenoic Acid; Fibroblasts; Humans; Lipoxins; NF-kappa B; Pulpitis; Sirtuin 1; Sirtuins

2022